Operating Lease, Right-of-Use Asset of Vaxcyte, Inc. from 01 Jan 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Vaxcyte, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2021 to 30 Sep 2025.
  • Vaxcyte, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $83,515,000, a 191% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Vaxcyte, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $83,515,000 +$54,815,000 +191% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $85,649,000 +$58,870,000 +220% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $87,759,000 +$58,854,000 +204% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $72,102,000 +$41,105,000 +133% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $28,700,000 +$12,367,000 +76% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 $26,779,000 +$8,773,000 +49% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $28,905,000 +$9,247,000 +47% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $30,997,000 +$9,709,000 +46% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 $16,333,000 -$6,554,000 -29% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $18,006,000 -$6,550,000 -27% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $19,658,000 -$6,463,000 -25% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $21,288,000 -$6,670,000 -24% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 $22,887,000 +$22,580,000 +7355% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $24,556,000 +$23,902,000 +3655% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $26,121,000 +$25,093,000 +2441% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $27,958,000 +$27,058,000 +3006% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q3 2021 $307,000 30 Sep 2021 10-Q 07 Nov 2022 2022 Q3
Q2 2021 $654,000 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q1 2021 $1,028,000 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 $900,000 01 Jan 2021 10-K 28 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.